Introduction to Ipamorelin Research In the evolution of Growth Hormone-Releasing Peptides (GHRPs), Ipamorelin represents a significant technological leap forward. Developed in the late 1990s by Novo Nordisk, this synthetic pentapeptide was engineered to solve the primary problem associated with earlier generation secretagogues: the unwanted elevation of secondary hormones. While peptides like GHRP-2, GHRP-6, and Hexarelin […]
